Invesco Biotechnology & G... (PBE)
NYSEArca: PBE
· Real-Time Price · USD
97.59
-0.67 (-0.68%)
At close: Aug 20, 2026, 3:59 PM
97.59
+0.02%
After-hours: 4:10 PM
Invesco Biotechnology & Genome ETF (PBE) ETF Price, Holdings & Analysis
-0.68% (1D)
| Bid | 0 |
| Market Cap | n/a |
| AUM | 281.95M |
| NAV | 98.30 |
| Beta | 0.79 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 26.26 |
| Shares Out | 4.55M |
| Inception Date | Jun 23, 2005 |
| Ask | 0 |
| Volume | 11,045 |
| Avg. Volume (20D) | 22,675 |
| Open | 97.29 |
| Previous Close | 98.26 |
| Day's Range | 96.44 - 97.57 |
| 52-Week Range | 67.41 - 98.32 |
| Holdings | n/a |
| Expense Ratio | 0.58% |
About PBE
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Asset Class Equity
Ticker Symbol PBE
Inception Date Jun 23, 2005
Provider Invesco
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 46.14% of assets
| Name | Symbol | Weight |
|---|---|---|
| Regeneron Pharmaceut... | REGN | 5.47% |
| Amgen Inc | AMGN | 5.22% |
| Caredx Inc | CDNA | 5.03% |
| Vertex Pharmaceutica... | VRTX | 4.98% |
| Royalty Pharma PLC C... | RPRX | 4.93% |
| Biogen Inc | BIIB | 4.78% |
| Gilead Sciences Inc | GILD | 4.43% |
| United Therapeutics ... | UTHR | 4.07% |
| Bio-techne Corp | TECH | 3.73% |
| Illumina Inc | ILMN | 3.50% |
Dividends Dividend Yield 1.59%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 22, 2026 | $0.8110 | n/a |
| Mar 23, 2026 | $0.0820 | n/a |
| Dec 22, 2025 | $0.4200 | n/a |
| Sep 22, 2025 | $0.2340 | n/a |
| Jun 23, 2025 | $0.1300 | n/a |
